286 related articles for article (PubMed ID: 10832771)
1. Overweight, obesity, and blood pressure: the effects of modest weight reduction.
Mertens IL; Van Gaal LF
Obes Res; 2000 May; 8(3):270-8. PubMed ID: 10832771
[TBL] [Abstract][Full Text] [Related]
2. [Obesity and hypertension].
Verdecchia P; Trimarco B
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
[TBL] [Abstract][Full Text] [Related]
3. Benefits of sustained moderate weight loss in obesity.
Pasanisi F; Contaldo F; de Simone G; Mancini M
Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):401-6. PubMed ID: 12055705
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
Sharma AM; Caterson ID; Coutinho W; Finer N; Van Gaal L; Maggioni AP; Torp-Pedersen C; Bacher HP; Shepherd GM; James WP;
Diabetes Obes Metab; 2009 Mar; 11(3):239-50. PubMed ID: 18671798
[TBL] [Abstract][Full Text] [Related]
5. Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
Leiter LA; Abbott D; Campbell NR; Mendelson R; Ogilvie RI; Chockalingam A
CMAJ; 1999 May; 160(9 Suppl):S7-12. PubMed ID: 10333848
[TBL] [Abstract][Full Text] [Related]
6. Data from the StEP TWO programme showing the effect on blood pressure and different parameters for obesity in overweight and obese primary school children.
Graf C; Rost SV; Koch B; Heinen S; Falkowski G; Dordel S; Bjarnason-Wehrens B; Sreeram N; Brockmeier K; Christ H; Predel HG
Cardiol Young; 2005 Jun; 15(3):291-8. PubMed ID: 15865832
[TBL] [Abstract][Full Text] [Related]
7. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
[TBL] [Abstract][Full Text] [Related]
8. The effects of weight reduction on blood pressure in 301 obese patients.
Schotte DE; Stunkard AJ
Arch Intern Med; 1990 Aug; 150(8):1701-4. PubMed ID: 2383165
[TBL] [Abstract][Full Text] [Related]
9. Reductions in blood pressure following energy restriction for weight loss do not rebound after re-establishment of energy balance in overweight and obese subjects.
Brinkworth GD; Wycherley TP; Noakes M; Clifton PM
Clin Exp Hypertens; 2008 Jul; 30(5):385-96. PubMed ID: 18633761
[TBL] [Abstract][Full Text] [Related]
10. Overweight, obesity and elevated blood pressure in children and adolescents.
Schiel R; Beltschikow W; Kramer G; Stein G
Eur J Med Res; 2006 Mar; 11(3):97-101. PubMed ID: 16751109
[TBL] [Abstract][Full Text] [Related]
11. Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study.
Moore LL; Visioni AJ; Qureshi MM; Bradlee ML; Ellison RC; D'Agostino R
Arch Intern Med; 2005 Jun; 165(11):1298-303. PubMed ID: 15956011
[TBL] [Abstract][Full Text] [Related]
12. [Dietetic-hygienic measures in the control of arterial hypertension in obese females].
Pecelj-Gec M; Jorga J; Marmut Z; Plećas D; Mirić G
Srp Arh Celok Lek; 1992; 120(9-10):273-5. PubMed ID: 1306018
[TBL] [Abstract][Full Text] [Related]
13. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
15. Effects of obesity reduction on cardiovascular risk factors: comparison of individual and group treatment--substudy of the Croatian Healthy Weight Loss Programme.
Jovanović Z; Crncević-Orlić Z; Stimac D; Kokić S; Persić V; Ruzić T; Goll-Barić S
Coll Antropol; 2009 Sep; 33(3):751-7. PubMed ID: 19860100
[TBL] [Abstract][Full Text] [Related]
16. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.
Clifton PM; Bastiaans K; Keogh JB
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):548-54. PubMed ID: 19179060
[TBL] [Abstract][Full Text] [Related]
17. Obesity and hypertension: epidemiological aspects of the relationship.
Heyden S; Schneider KA
J Hum Hypertens; 1990 Aug; 4(4):431-5. PubMed ID: 2258890
[TBL] [Abstract][Full Text] [Related]
18. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.
Madsen EL; Bruun JM; Skogstrand K; Hougaard DM; Christiansen T; Richelsen B
Metabolism; 2009 Jul; 58(7):946-53. PubMed ID: 19409578
[TBL] [Abstract][Full Text] [Related]
19. Change in body mass index and its impact on blood pressure: a prospective population study.
Drøyvold WB; Midthjell K; Nilsen TI; Holmen J
Int J Obes (Lond); 2005 Jun; 29(6):650-5. PubMed ID: 15809666
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study.
Sjöström CD; Peltonen M; Sjöström L
Obes Res; 2001 Mar; 9(3):188-95. PubMed ID: 11323444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
